BC Trials and COVID-19
Conducting Research in a Pandemic: How We Are Getting Breast Cancer Trials Back up and Running
Hope S. Rugo
Hope S. Rugo, MD

Pretest

Progress
1 2
Course Completed
1.
Which of the following is NOT one of the outcome metrics provided to member hospitals by JANIS, a national program to track AMR in Japan?
2.
Improved utilization of diagnostics for AMR surveillance can include all of the following, EXCEPT:
3.
Which of the following is NOT a challenge to communicable disease control, specifically in South and South-East Asia?
4.

Is sky blue?